AC Immune SA (ACIU)
2.73
-0.11
(-3.87%)
USD |
NASDAQ |
Mar 05, 16:00
2.78
+0.05
(+1.83%)
After-Hours: 20:00
AC Immune Cash from Investing (TTM) : 56.51M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Novartis AG | -4.902B |
| EvoNext Holdings SA | 4.034M |
| Kuros Biosciences Ltd. | -1.824M |
| Basilea Pharmaceutica AG | -3.579M |
| Santhera Pharmaceuticals Holding AG | -0.1636M |